BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 23886298)

  • 21. Major malformation risk, pregnancy outcomes, and neurodevelopmental outcomes associated with metformin use during pregnancy.
    Andrade C
    J Clin Psychiatry; 2016 Apr; 77(4):e411-4. PubMed ID: 27137425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J;
    Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications.
    De Leo V; Musacchio MC; Piomboni P; Di Sabatino A; Morgante G
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):63-6. PubMed ID: 21530058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.
    Ghazeeri GS; Nassar AH; Younes Z; Awwad JT
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):658-78. PubMed ID: 22375613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety considerations with pharmacological treatment of gestational diabetes mellitus.
    Simmons D
    Drug Saf; 2015 Jan; 38(1):65-78. PubMed ID: 25542297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should we continue or stop insulin sensitizing drugs during pregnancy?
    Norman RJ; Wang JX; Hague W
    Curr Opin Obstet Gynecol; 2004 Jun; 16(3):245-50. PubMed ID: 15129054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes.
    Barbour LA; Scifres C; Valent AM; Friedman JE; Buchanan TA; Coustan D; Aagaard K; Thornburg KL; Catalano PM; Galan HL; Hay WW; Frias AE; Shankar K; Simmons RA; Moses RG; Sacks DA; Loeken MR
    Am J Obstet Gynecol; 2018 Oct; 219(4):367.e1-367.e7. PubMed ID: 29959933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
    Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
    Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria.
    Helseth R; Vanky E; Salvesen O; Carlsen SM
    Eur J Endocrinol; 2013 Jul; 169(1):65-72. PubMed ID: 23636445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis.
    Guo L; Ma J; Tang J; Hu D; Zhang W; Zhao X
    J Diabetes Res; 2019; 2019():9804708. PubMed ID: 31781670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-insulin pharmacological therapy in pregnancy.
    Bajaj S
    J Pak Med Assoc; 2016 Sep; 66(9 Suppl 1):S45-7. PubMed ID: 27582151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
    Glueck CJ; Pranikoff J; Aregawi D; Wang P
    Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin: From Research to Clinical Practice.
    Tan MH; Alquraini H; Mizokami-Stout K; MacEachern M
    Endocrinol Metab Clin North Am; 2016 Dec; 45(4):819-843. PubMed ID: 27823607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: A systematic review and meta-analysis.
    Tarry-Adkins JL; Aiken CE; Ozanne SE
    PLoS Med; 2019 Aug; 16(8):e1002848. PubMed ID: 31386659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
    Nawaz FH; Rizvi J
    Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: a case report.
    Guido M; Romualdi D; Belosi C; Selvaggi L; Lanzone A
    J Endocrinol Invest; 2004 Jan; 27(1):70-5. PubMed ID: 15053248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial.
    Niromanesh S; Alavi A; Sharbaf FR; Amjadi N; Moosavi S; Akbari S
    Diabetes Res Clin Pract; 2012 Dec; 98(3):422-9. PubMed ID: 23068960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of metformin for gestational diabetes mellitus in clinical practice: Has it had an impact?
    Gandhi P; Bustani R; Madhuvrata P; Farrell T
    Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):147-50. PubMed ID: 22137984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and gestational diabetes.
    Glueck CJ; Goldenberg N; Streicher P; Wang P
    Curr Diab Rep; 2003 Aug; 3(4):303-12. PubMed ID: 12866993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis.
    Butalia S; Gutierrez L; Lodha A; Aitken E; Zakariasen A; Donovan L
    Diabet Med; 2017 Jan; 34(1):27-36. PubMed ID: 27150509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.